To confirm the SF3B1 mutation was related to the CLL and not the patient's MDS, an NGS report was reviewed from a bone marrow biopsy from December 2018 in which MDS was present with no evidence of CLL. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.